SIRT7 PROTECTS LIVER FIBROSIS BY SUPPRESSING STELLATE CELL ACTIVATION VIA THE TGF-Β/SMAD2/3 PATHWAY

被引：0
|
作者：
Ding, Cong [1 ]
Liu, Bohao [1 ]
Yu, Tingzi [1 ]
Wang Zhiqiang [1 ]
Tang, Wenbin [1 ]
Li, Zhuan [1 ]
机构：
[1] Hunan Normal Univ, Changsha, Peoples R China
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3428-A
引用
收藏
页码：S1530 / S1530
页数：1
相关论文
共 50 条
  • [1] MicroRNA-30a depresses hepatic stellate cell activation against liver fibrosis through blockade of the TGF-β1/Smad2/3 pathway
    Pan, Yipeng
    You, Bo
    Zhao, Xue
    Li, Wei
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 40 (03) : 2036 - 2050
  • [2] Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway
    Mu, Mao
    Zuo, Shi
    Wu, Rong-Min
    Deng, Kai-Sheng
    Lu, Shuang
    Zhu, Juan-Juan
    Zou, Gao-Liang
    Yang, Jing
    Cheng, Ming-Liang
    Zhao, Xue-Ke
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 4107 - 4115
  • [3] Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
    Meng, Xiao Ming
    Huang, Xiao Ru
    Chung, Arthur C. K.
    Qin, Wei
    Shao, Xinli
    Igarashi, Peter
    Ju, Wenjun
    Bottinger, Erwin P.
    Lan, Hui Yao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (09): : 1477 - 1487
  • [4] Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
    Gao-Liang Zou
    Shi Zuo
    Shuang Lu
    Rui-Han Hu
    Yin-Ying Lu
    Jing Yang
    Kai-Sheng Deng
    Ye-Ting Wu
    Mao Mu
    Juan-Juan Zhu
    Jing-Zhang Zeng
    Bao-Fang Zhang
    Xian Wu
    Xue-Ke Zhao
    Hai-Yang Li
    World Journal of Gastroenterology, 2019, 25 (30) : 4222 - 4234
  • [5] Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
    Zou, Gao-Liang
    Zuo, Shi
    Lu, Shuang
    Hu, Rui-Han
    Lu, Yin-Ying
    Yang, Jing
    Deng, Kai-Sheng
    Wu, Ye-Ting
    Mu, Mao
    Zhu, Juan-Juan
    Zeng, Jing-Zhang
    Zhang, Bao-Fang
    Wu, Xian
    Zhao, Xue-Ke
    Li, Hai-Yang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (30) : 4222 - 4234
  • [6] Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway
    Zhou, Ling
    Dong, Xiaoying
    Wang, Linlin
    Shan, Lanlan
    Li, Ting
    Xu, Wanfu
    Ding, Yan
    Lai, Mingqiang
    Lin, Xiaojun
    Dai, Meng
    Bai, Xiaochun
    Jia, Chunhong
    Zheng, Hang
    ONCOTARGET, 2017, 8 (34) : 56267 - 56280
  • [7] Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway
    Balta, Cornel
    Herman, Hildegard
    Boldura, Oana Maria
    Gasca, Ionela
    Rosu, Marcel
    Ardelean, Aurel
    Hermenean, Anca
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 240 : 94 - 101
  • [8] REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway
    Cho, Sam Seok
    Lee, Ji Hyun
    Kim, Kyu Min
    Park, Eun Young
    Ku, Sae Kwang
    Cho, Il Je
    Yang, Ji Hye
    Ki, Sung Hwan
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 176 : 246 - 256
  • [9] LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway
    Yang, Ya-ru
    Bu, Fang-tian
    Yang, Yang
    Li, Hao
    Huang, Cheng
    Meng, Xiao-ming
    Zhang, Lei
    Lv, Xiong-wen
    Li, Jun
    MOLECULAR IMMUNOLOGY, 2020, 126 : 31 - 39
  • [10] The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation
    Xiao, Zhicheng
    Zhang, Jing
    Peng, Xiaogang
    Dong, Yanjun
    Jia, Lixin
    Li, Huihua
    Du, Jie
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 55 : 65 - 71
12345